20208 ⎘
Medicinal preparations containing organic active ingredients; Sulfur, selenium, or tellurium compounds, e.g. thiols Sulfides; Sulfoxides; Sulfones
COMPOSITION FOR ENHANCING ADRENOMEDULLIN GENE EXPRESSION
#2Complexes and Compounds of Mercaptophenols and Curcumin for Therapeutic Applications
#3DIETARY SUPPLEMENT FORMULATION AND METHOD OF PREPARATION THEREOF
#4ANTIMICROBIAL COMPOSITIONS
#5FACE AND BODY OIL COMPOSITION
#6GLYCOPYRROLATE SALTS
#7SYSTEMS FOR GENERATING PERSONALIZED DIETARY SUPPLEMENTS
#8NUTRACEUTICAL COMPOSITION OF HYALURONIC ACID
#9AROMATIC COMPOUND AND USE THEREOF
#10PHENYLALANINE-BASED LAT1 INHIBITORS AND USES THEREOF
#11NOVEL ORAL CARE FORMULATIONS FOR TREATMENT OF XEROSTOMIA
#12PHENYLALANINE-BASED LAT1 INHIBITORS AND USES THEREOF
#13DIETARY SLEEP SUPPLEMENT
#14COMPOSITION OF MALUS NIEDZWETZKYANA DIECK AND PRUNUS CERASIFERA EHRHART AND USE THEREOF IN TERMS OF RESISTING ATHEROSCLEROSIS
#15GPR40 AGONISTS
#16PRENATAL SUPPLEMENT
#17COMBINATION THERAPY FOR THE TREATMENT OF CANCER METASTASES
#18ANTISEPTIC, ANTISEBORRHEIC, EXFOLIATING COMPOSITION TO REMOVE OR PREVENT ACNE
#19TETRALIN AND TETRAHYDROQUINOLINE COMPOUNDS AS INHIBITORS OF HIF-2ALPHA
#20Topical Pain Cream
#21GLYCOPYRROLATE SALTS
#22Equine Supplement Composition
#23HYDRODYNAMIC GENE DELIVERY
#24COMBINATION THERAPY OF A TYPE II ANTI-CD20 ANTIBODY WITH A SELECTIVE BCL-2 INHIBITOR
#25PHARMACEUTICAL COMPOSITIONS AND METHODS OF ADMINISTRATION
#26Topical Sports Cream Composition
#27BISPHENOL DERIVATIVES AND THEIR USE AS ANDROGEN RECEPTOR ACTIVITY MODULATORS
#28COMPOSITIONS FOR REMOVING NECROTIC OR INFECTED TISSUES FROM BODY SURFACE LESIONS AND FROM ORAL CAVITY
#29USE OF PEG-BASED INTERPOLYMER COMPLEXES FOR IMPROVED SOLUBILIZATION F BCS CLASS II DRUGS
#30PREPARATION OF A THERAPEUTIC COMPOSITION FOR TREATING AUTOIMMUNE DISEASES
#31Micronutrient composition to prevent and reverse protein glycation during oxidative stress in human
#32DEVICES AND METHOD FOR PREVENTION AND TREATMENT OF FUNGAL AND BACTERIAL MICROORGANISMS
#33Methods of Treating Mitochondrial Dysfunction
#345-HYDROXYMETHYLFURFURAL FOR THE TREATMENT OF MITOCHONDRIAL DYSFUNCTION
#35METHODS FOR TREATMENT OF PATIENTS WITH MYELODYSPLASTIC SYNDROMES
#36PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING INTERSTITIAL CYSTITIS/BLADDER PAIN SYNDROME
#37METHODS AND COMPOSITIONS FOR THE TREATMENT OF CANCER
#38COMPOSITIONS AND METHODS FOR TREATING BIOFILM DISORDERS AND INFECTIONS
#39Compositions Of Dimethyl Trisulfide (DMTS) As A Cyanide Antidote
#40MICROSCALE THERMOPHORESIS TO EVALUATE CHANNEL LIPID INTERACTIONS AND METHODS OF TREATING NAV CHANNELS RELATED DISEASES
#41Medication for Alleviating Parkinson's Symptoms and Method of Administering
#42SALT FORM AND CRYSTAL FORM OF HETEROCYCLIC SUBSTITUTED PURINONE DERIVATIVE
#43Tetralin and tetrahydroquinoline compounds as inhibitors of HIF-2alpha
#44ACID ADDITION SALT OF ROCK INHIBITOR, AND CRYSTAL FORM, COMPOSITION AND PHARMACEUTICAL USE THEREOF
#45TREATMENT OF NEUROLOGICAL DISORDERS
#46TOPICAL FORMULATIONS COMPRISING BENZOYL PEROXIDE AND AZELAIC ACID, AND USE THEREOF
#47COMBINATION THERAPY OF A TYPE II ANTI-CD20 ANTIBODY WITH A SELECTIVE BCL-2 INHIBITOR
#48NUCLEIC ACID CONSTRUCTS AND USES THEREOF
#49COMBINATION THERAPY OF A TYPE II ANTI-CD20 ANTIBODY WITH A SELECTIVE BCL-2 INHIBITOR
#50METHOD OF TREATING A PERSON AFFLICTED WITH A RESPIRATORY CONDITION AND PHARMACEUTICAL FORMULATION INCLUDING DAPSONE
#51BOTANICALS AS WNT/BETA-CATENIN ACTIVATORS, MOLECULAR PATHWAY REGULATORS, TISSUE REGENERATORS AND HEALTH BIOMARKER REGULATORS
#52PHARMACEUTICAL COMPOSITION FOR TREATING CANCER, AND PREPARATION METHOD AND USE THEREOF
#53METHOD OF TREATING PROGRESSIVE HEART FAILURE IN SUBJECTS WITH CLASS II HEART FAILURE
#54PHARMACEUTICAL COMPOSITION FOR INHIBITING CANCER METASTASIS
#55Agmatine compositions for treatment of osteoarthritis
#56ANTI-CANCER COMPOSITION CONTAINING AURANOFIN AND MERCAPTO COMPOUND AND USE THEREOF
#57COMPOSITION FOR ENHANCING ADRENOMEDULLIN GENE EXPRESSION
#58Processes for the Preparation of Multicomponent Crystalline Forms of Active Pharmaceutical Ingredients Using Solvent Vapour
#59COMBINATION THERAPY OF A TYPE II ANTI-CD20 ANTIBODY WITH A SELECTIVE BCL-2 INHIBITOR
#60TOPICAL COMPOSITIONS AND METHODS FOR TREATING PAIN
#61COMPOUNDS, COMPOSITIONS, AND METHODS FOR THE TREATMENT AND PREVENTION OF AVIAN PATHOGENIC E. COLI (APEC)
#62ANTIMICROBIAL COMPOSITION
#63Extended release plastic formulation
#64ECTOPARASITICIDE VETERINARY COMPOSITION
#65COMBINATION THERAPY OF A TYPE II ANTI-CD20 ANTIBODY WITH A SELECTIVE BCL-2 INHIBITOR
#66METHODS FOR TREATMENT OF INTERSTITIAL CYSTITIS
#67METHODS, DEVICES, AND SYSTEMS FOR TREATING LENS PROTEIN AGGREGATION DISEASES
#68DIMETHYL SULFOXIDE (DMSO) AND METHYLSULFONYLMETHANE (MSM) FORMULATIONS TO TREAT OSTEOARTHRITIS
#69COMBINATION THERAPY OF A TYPE II ANTI-CD20 ANTIBODY WITH A SELECTIVE BCL-2 INHIBITOR
#70DIMETHYL SULFONE FOR TREATMENT OF CHRONICALLY HEAT STRESSED POULTRY
#71TREATMENT METHODS AND FORMULATIONS
#72Antiseptic, antiseborrheic, exfoliating composition to remove or prevent acne
#73Mechanochemical dynamic for focal cancer treatment
#74DIMETHYL SULFOXIDE (DMSO) FORMULATIONS FOR TREATING AUTISM
#75LYSOSOME-TARGETING ANTIBODY-DRUG CONJUGATE AND USE THEREOF
#76COMPOSITIONS FOR ALLEVIATING THE SYMPTOMS OF LOW ANTERIOR RESECTION SYNDROME BY TOPICAL ADMINISTRATION TO THE NEORECTUM
#77COMPOSITION, ARTICLE AND METHOD FOR AFFECTING A MAMMAL
#78Methods and compositions for the treatment of snake bite
#79COMPOSITIONS FOR REMOVING NECROTIC OR INFECTED TISSUES FROM BODY SURFACE LESIONS
#80Extended release plastic formulation
#81N-(FURAN-2-YLMETHYL)-7H-PURIN-6-AMINE FOR TREATMENT OF CIRCADIAN RHYTHM DISEASES, DISORDERS AND DYSFUNCTIONS
#82Method of treating a person afflicted with COVID-19 and pharmaceutical formulation including dapsone
#83Tetralin and tetrahydroquinoline compounds as inhibitors of HIF-2alpha
#84ACELLULAR PLACENTAL THERAPIES FOR NECROTIZING ENTEROCOLITIS
#85Compositions for removing necrotic or infected tissues from body surface lesions and from oral cavity
#86Anticancer compounds
#87UREA, AMIDE, AND SUBSTITUTED HETEROARYL COMPOUNDS FOR CBL-B INHIBITION
#88Detection of a defect on HLA-E restricted CD8+ T regulatory cells
#89Method for treating type I diabetes with peptide-loaded dendritic cells
#90Method for treating multiple sclerosis with peptide-loaded dendritic cells
#91SmartCore compositions and methods
#92Combination therapy of a type II anti-CD20 antibody with a selective BCL-2 inhibitor
#93ADMINISTRATION OF SERINE PROTEASE INHIBITORS TO THE STOMACH
#94COMPOSITION WITH DRUG MICRO-NANO PARTICLES OF AN ANTI-CANCER AGENT
#95Composition for Collagen-Based Drink Mix
#96SMALL MOLECULE INHIBITORS OF A PROTEIN COMPLEX
#97GPR40 agonists
#98GLYCOPYRROLATE SALTS
#99HEALTH PRODUCTS FROM GARLIC GREEN TOPS
#100METHOD FOR PREDICTING EFFECTIVENESS OF TREATMENT OF HEMOGLOBINOPATHY
#101Medication for Alleviating Parkinson's Symptoms and Method of Administering
#102COMPOSITIONS AND METHODS FOR TREATING NEUROCOGNITIVE DISORDERS
#103METHODS AND COMPOSITIONS FOR TREATMENT OF CANCER
#104MULTI-SUPPLEMENT COMPOSITIONS
#105COMPOSITIONS AND METHODS FOR TREATING NEUROCOGNITIVE DISORDERS
#106COMPOSITION FOR PREVENTING AND TREATING MICROBIAL DISEASE
#107PROCESS FOR REMOVING IONS FROM BODILY FLUIDS USING SMALL MOLECULE METAL CHELATORS AND METALLATE ION EXCHANGE COMPOSITIONS
#108COMPLEXES AND COMPOSITIONS COMPRISING PROBUCOL AND USES THEREOF
#109Compositions with agents for mitigating methanogenesis in animals and related methods
#110COMPOSITIONS AND METHODS FOR TREATING CARDIAC INJURY
#111COMPOSITIONS AND METHODS FOR TREATING OCULAR CONDITIONS
#112SURFACTANTS FOR THE TREATMENT OF CONDITIONS THROUGH TARGETED NECROSIS
#113TRANSDERMAL COMPOSITION
#114Compounds and compositions comprising the same for treating hypertension or heart failure
#115Liquid invisible mask with broad-spectrum bacteriostasis and preparation method and using method thereof
#116Synthetic Antibacterial Compounds and Uses Thereof
#117METHOD OF ENCAPSULATING ACTIVE INGREDIENTS IN LIPOSOMES
#118COMPOSITIONS AND METHODS FOR THE MANAGEMENT OF MUCOSITIS IN MAMMALS
#119DIETARY SUPPLEMENT COMPOSITIONS
#120Bisphenol derivatives and their use as androgen receptor activity modulators
#121Inhibition of Acetyl-CoA Metabolism for Treatment and Prevention of Immune System Diseases and Disorders
#122Topical composition for pain relief
#123Compounds, compositions, and methods for the treatment and prevention of avian pathogenic (APEC)
#124TOPICAL FORMULATIONS AND METHODS OF USE THEREOF
#125Tetralin and tetrahydroquinoline compounds as inhibitors of HIF-2α
#126Methods of Treating Mitochondrial Dysfunction
#127Cannabidiol Combination Compositions
#128Compositions and methods for treatment of mitochondrial respiratory chain dysfunction and other mitochondrial disorders
#129Compounds for inhibition of inflammation
#130METHYL SULFONYL METHANE-CONTAINING COMPOSITION FOR PREVENTING OR ALLEVIATING OBESITY, FATTY LIVER, AND DIABETES
#131Topical composition and delivery system and its use
#132SURFACTANTS FOR TREATMENT OF CONDITIONS THROUGH TARGETED NECROSIS
#133SYSTEMS AND METHODS FOR DETERMINING A TREATMENT COURSE OF ACTION
#134Administration of serine protease inhibitors to the stomach
#135METHODS FOR TREATMENT OF INTERSTITIAL CYSTITIS
#136Method of encapsulating active ingredients in liposomes
#137Composition and method for orally administering one or more active agents to a pet
#138Pet Food Supplement
#139Interactional Biosystem
#140COMPOSITIONS AND METHODS FOR TREATING AND PREVENTING PROTEINURIA AND ENDOTHELIAL EROSION
#141Topical formulations comprising strontium and methylsulfonylmethane (MSM) and methods of treatment
#142ANTISEPTIC, ANTISEBORRHEIC AND EXFOLIATING COMPOSITION TO REMOVE OR PREVENT ACNE
#143METHODS AND USE OF COMPOUNDS THAT BIND TO RELA OF NF-KB
#144METHOD OF TRANSPORTING AN AGENT ACROSS BLOOD-BRAIN, BLOOD-COCHLEAR OR BLOOD-CEREBROSPINAL FLUID BARRIER
#145Treatment of lysosomal storage disorders
#146Antiseptic composition comprising unithiol and dimethylsulfoxide, use of the composition and method of wound treatment with its use
#147Inhibitors of GRB2-associated binding protein 1 (GAB1) and methods of treating cancer using the same
#148DIETARY SUPPLEMENT COMPOSITIONS FOR TREATING NEUROLOGICAL DISORDERS, AND METHODS OF TREATING NEUROLOGICAL DISORDERS USING SAME
#149USE OF INHIBITORS OF IL-36 PROTEOLYTIC PROCESSING FOR THE TREATMENT AND/OR REDUCTION OF INFLAMMATION
#150Compositions having antifungal activity
#151METHOD OF THERAPEUTIC ADMINISTRATION OF DHE TO ENABLE RAPID RELIEF OF MIGRAINE WHILE MINIMIZING SIDE EFFECT PROFILE
#152TREATMENT OF PAIN WITH TOPICAL DICLOFENAC
#153TOPICAL APPLICATION OF MEDICAL CANNABIS
#154Compositions of dimethyl trisulfide (DMTS) as a cyanide antidote
#155Transdermal Composition
#156Bisphenol derivatives and their use as androgen receptor activity modulators
#157FLUORENE COMPOUND AND PHARMACEUTICAL USE THEREOF
#158Composition of Athletic and Fitness Supplements, Method for Production and Method for Pulmonary Administration of Same
#159DIMETHYL SULFOXIDE (DMSO) AND METHYLSULFONYLMETHANE (MSM) FORMULATIONS TO TREAT OSTEOARTHRITIS
#160METHOD FOR PREVENTION AND TREATMENT OF ACNE, ECZEMA, PSORIASIS, AND RELATED DERMATOLOGICAL CONDITIONS WITH COMPOSITION COMPRISING A SPHINGOLIPID AND SULPHUR COMPOUNDS
#161Methods for treatment of patients with myelodysplastic syndromes
#162Compositions having ginger-curcumin and certain additives
#163METHODS AND COMPOSITIONS FOR THE TREATMENT OF CANCER
#164ADMINISTRATION OF SERINE PROTEASE INHIBITORS TO THE STOMACH
#165ALL-NATURAL TOPICAL PAIN RELIEF OINTMENT
#166PHOTOSENSITISING COMPOSITION AND ITS USES
#167ARYL ETHERS AND USES THEREOF
#168ROR gamma (RORγ) modulators
#169SURFACTANTS FOR THE TREATMENT OF CONDITIONS THROUGH TARGETED NECROSIS
#170Necrosis inhibitors
#171DIMETHYL SULFOXIDE (DMSO) FORMULATIONS FOR TREATING AUTISM
#172Topical composition for pain relief
#173Methods for inhibiting conversion of choline to trimethylamine (TMA)
#174COMPOSITIONS AND METHODS FOR TREATING OCULAR DISEASES
#175Aromatic 2-nitrosulfonyl fluoride antibiotics and methods of use thereof
#176Methods and Systems for Modulating Hormones and Related Methods, Agents and Compositions
#177CRYOPRESERVED PLATELET COMPOSITIONS AND METHODS FOR MAKING
#178METHODS AND COMPOSITIONS FOR TREATING JOINT DISEASE
#179Antimicrobial garlic compositions
#180TOPICAL PREPARATION FOR PAIN RELIEF
#181Use of recombinant lymphocyte activation gene-3 as a companion therapeutic for patients at risk for cardiovascular disease and other chronic inflammatory diseases
#182Inhibitors of hepatitis C virus
#183Hydrogen sulfide and/or nitrite in the treatment and prevention of atrial fibrillation
#184Composition and method for orally administering one or more active agents to a pet
#185Inhibition of Acetyl-CoA Metabolism for Treatment and Prevention of Immune System Diseases and Disorders
#186VOLATILE ORGANIC COMPOUNDS FOR INHIBITING FUNGAL GROWTH
#187Pharmaceutical hydrocortisone solution for an injection device
#188A NOVEL ROLE FOR TERMINAL RNA URIDYLATION AND RNA TURNOVER IN ONCOGENESIS
#189METHOD AND KIT FOR MYOCARDIAL REPERFUSION, AND METHOD FOR ATTENUATING OR REDUCING MYOCARDIAL REPERFUSION INJURY
#190Antiseptic, antiseborrheic and exfoliating composition to remove or prevent acne
#191Anticancer compounds
#192TREATMENT OF PAIN WITH TOPICAL DICLOFENAC
#193Feminine hygiene products
#194Topical composition and delivery system and its use
#195METHOD OF THERAPEUTIC ADMINISTRATION OF DHE TO ENABLE RAPID RELIEF OF MIGRAINE WHILE MINIMIZING SIDE EFFECT PROFILE
#196COMPOSITIONS AND METHODS FOR TREATING OCULAR DISEASES
#197N-ACETYL CYSTEINE BASED COMPOSITIONS
#198BIFUNCTIONAL ANTIFUNGAL AGENTS AND METHODS OF TREATING FUNGAL INFECTION
#199SUSTAINED-RELEASE COMPOSITION, METHOD FOR FABRICATING, AND USE THEREOF
#200TOPICAL PAIN RELIEF COMPOSITION
#201Use Of 2,5-Dihydroxybenzene Compounds And Derivatives For The Treatment Of Skin Cancer
#202Use Of 2,5-Dihydroxybenzene Compounds And Derivatives For The Treatment Of Rosacea
#203FLUORENE COMPOUND AND PHARMACEUTICAL USE THEREOF
#204Administration of serine protease inhibitors to the stomach
#205Compositions and methods for treating and preventing proteinuria and endothelial erosion
#206Use of isothiocyanate compounds
#207Methods for treatment of interstitial cystitis
#208Challenge test for diagnosing subtypes of ASD
#209Method of identifying ASD phenotype 1 patients
#210Treatment of a subtype of ASD
#211Aryl ethers and uses thereof
#212ROR GAMMA (RORy) MODULATORS
#213COMPOSITION FOR TREATING ALOPECIA AND METHODS OF MAKING AND USING THE SAME
#214Methods for inhibiting conversion of choline to trimethylamine (TMA)
#215TKI permeability enhancers
#216Method of decreasing protein-aldehyde adducts by administering a mixed disulfide of n-acetylcysteine and propyl mercaptan, propenyl mercaptan, or allyl mercaptan
#217Methods and dose packs for monitoring medication adherence
#218Necrosis inhibitors
#219ION CHANNEL ACTIVATORS AND METHODS OF USE
#220Composition having antifungal activity
#221Compositions for Use in Treating Pulmonary Arterial Hypertension
#222Agent for preventing and/or treating Alzheimer's disease
#223Inhibitors of hepatitis C virus
#224DIETARY SUPPLEMENTS AND FORMULATIONS
#225DIETARY SUPPLEMENTS AND FORMULATIONS
#226Pharmaceutical composition for prevention, treatment or delay of Alzheimer's disease or dementia containing G protein-coupled receptor 19 agent as active ingredient
#227SHIP1 MODULATORS AND METHODS RELATED THERETO
#228ANTISEPTIC, ANTISEBORRHEIC AND EXFOLIATING COMPOSITION TO REMOVE OR PREVENT ACNE
#229COMPOSITIONS AND METHODS FOR TREATING PERITONEAL CANCERS
#230Sustained-release composition, method for fabricating, and use thereof
#231Inhibition of multiple pathogenic agents using bithionol
#232COMPOUNDS AND COMPOSITIONS FOR TREATMENT OF BREAST CANCER
#233THERAPEUTIC PUTTY HAVING ANALGESICS AND/OR COUNTERIRRITANTS
#234Necrosis inhibitors
#235Use of ceranib-2 in the treatment of lung cancer
#236Covalent irreversible inhibitors of USP7 as anti-cancer agents
#237Dimethyl sulfoxide (DMSO) or DMSO and methylsulfonylmethane (MSM) formulations to treat infectious diseases
#238Dihydroindene and tetrahydronaphthalene compounds
#239N-acetyl cysteine based compositions
#240USE OF HYDROGEN SULFIDE TO PREVENT LENS OPACIFICATION
#241Compositions for use in treating pulmonary arterial hypertension
#242ROR gamma (RORγ) modulators
#243SHIP1 modulators and methods related thereto
#244Aryl ethers and uses thereof
#245Foamable formulation
#246Lyophilized mesna compositions
#247Treatment of pain with topical diclofenac
#248Non-peptidic GAPDH aggregation inhibitor
#249Pharmaceutical composition for prevention, treatment or delay of Alzheimer's disease or dementia containing G protein-coupled receptor 19 agent as active ingredient
#250DIMETHYL SULFOXIDE (DMSO) AND METHYLSULFONYLMETHANE (MSM) FORMULATIONS TO TREAT OSTEOARTHRITIS
#251Compositions of additives to ginger-curcumin to facilitate growth of fibroblasts and collagen
#252Method for treating a glycoprotein-related disease
#253Methods and use of compounds that bind to RelA of NF-kB
#254Introduction of alkyl substituents to aromatic compounds
#255Organometallic compound
#256HIF-2-ALPHA INHIBITOR POLYMORPHS
#257Use of 2,5-dihydroxybenzene derivatives for treating dermatitis
#258Use of 2,5-dihydroxybenzene compounds and derivatives for the treatment of glioma
#259Lyophilized mesna compositions
#260Compounds and methods for inhibiting NHE-mediated antiport in the treatment of disorders associated with fluid retention or salt overload and gastrointestinal tract disorders
#261Aqueous composition
#262Crystalline N-[5-(aminosulfonyl)-4-methyl-1,3-thiazol-2-yl]-N-methyl-2[4-(2-pyridinyl)phenyl]acetamide mono mesylate monohydrate having a specific particle size distribution range and a specific surface area range for use in pharmaceutical formulations
#263An Antimicrobial Composition
#264COMPOSITIONS AND FORMULATIONS OF GLUCOSAMINE FOR TRANSDERMAL AND TRANSMUCOSAL ADMINISTRATION
#265Anti-leukocyte adhesion for the mitigation of potential adverse events caused by CD3-specific binding domains
#266Methods and dose packs for monitoring medication adherence
#267Compositions and methods for treating ocular diseases
#268Self assembled gels for controlled delivery of encapsulated agents to cartilage
#269Use of recombinant lymphocyte activation gene-3 as a companion therapeutic for patients at risk for cardiovascular disease and other chronic inflammatory diseases
#270Inhibitors of GRB2-associated binding protein 1 (GAB1) and methods of treating cancer using the same
#271COMBINATION THERAPY FOR THE TREATMENT OF DEPRESSION AND OTHER NON-INFECTIOUS DISEASES
#272HIF-2α inhibitors for treating iron overload disorders
#273Necrosis inhibitors
#274BISPHENOL DERIVATIVES AND THEIR USE AS ANDROGEN RECEPTOR ACTIVITY MODULATORS
#275Decubitus Ulcer Salve
#276INHIBITORS OF HEPATITIS C VIRUS
#277Necrosis inhibitors
#278Method for treatment of inflammatory skin disorders with inhibitors of IL-36 proteolytic processing
#279Azaindole derivative having AMPK-activating activity
#280COMPOSITIONS, METHODS FOR MAKING THE COMPOSITIONS, AND METHODS FOR TREATING JOINT DISEASE
#281VOLATILE ORGANIC COMPOUNDS FOR INHIBITING FUNGAL GROWTH
#282Composition for the treatment of arthropathies and osteoarthritis
#283Administration of serine protease inhibitors to the stomach
#284SHIP1 modulators and methods related thereto
#285METHODS FOR TREATING ACUTE ACOUSTIC TRAUMA
#286ANTIMICROBIAL COMPOSITIONS
#287Method of therapeutic administration of DHE to enable rapid relief of migraine while minimizing side effect profile
#288APPLICATION OF TOPICAL PRODUCT USING A SONIC DEVICE
#289Organosulfur compounds for the prevention and treatment of neurodegenerative diseases
#290Compositions comprising eicosapentaenoic acid and a hydroxyl compound and methods of use thereof
#291Organosulfur compounds for the prevention and treatment of neurodegenerative diseases
#292Composition for Prevention and Treatment of Joint Pain and the Method of Preparation Thereof
#293Use of organic sulphur, antioxidants, and amino acids in conjunction with exercise and electromagnetic stimulation to treat osteoporosis
#294Use of 2,5-dihydroxybenzene compounds and derivatives for the treatment of skin cancer
#295Therapeutic compositions
#296Method for treating a glycoprotein-related disease
#297METHODS FOR SCREENING ANTIMICROBIAL AND ANTIVIRAL COMPOUNDS AND USES THEREOF
#298Compositions and methods for treating peritoneal cancers
#299Methods and compositions for treating cancer through inhibition of PI3K
#300COMPOSITION AND METHOD OF DELIVERY OF L-ARABINOSE AND SELECT COMPOUNDS